InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Matsui Connie, Director. Insider active across 2 companies, notably Halozyme Therapeutics, INC.. In total, 8 disclosures have been published. Split: 1 buy · 1 sell. Total volume traded: €710k. History available since 5 May 2021. The latest transaction was disclosed on 15 October 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Matsui Connie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
50,000 shares@ US$0.799100.0% of flowCommon StockSEC:0001236537-25-000006:0
Canonical exit: 13 Jan 2026 (T+90)
10,470 shares0Common StockSEC:0001415889-24-028062:0
6,501 shares0Common StockSEC:0001415889-24-011698:0
8,065 shares0Common StockSEC:0001415889-23-007692:0
9,250 shares0Common StockSEC:0001415889-22-011512:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002910:0
19,452 shares@ US$40.126100.0% of flowCommon StockSEC:0001179110-21-009910:0
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004973:0
8 of 8 declarations
About Matsui Connie
Connie Matsui is a Board Member at Halozyme Therapeutics, Inc., a biopharmaceutical company. As a board member, Connie contributes to the company's governance and the development of strategies aimed at enhancing its performance. Her experience in the biopharmaceutical sector is an asset to the board.
